Abstract
Biological research and clinical testing frequently require simultaneous quantification of multiple biomarkers for accurate disease diagnosis. In particular, the application of nanopore technology to real-sample analysis is limited in terms of discriminating multiple analytes in a mixture. In this study, we designed a series of highly specific double-stranded DNA-based probes and used them for synchronous detection of and discrimination among three protein biomarkers associated with lung cancer in a single nanopore. The probe could specifically identify and bind to the target, releasing an output DNA hybrid that generated signature current signals upon translocation through the nanopore. DNA hybrids with different hybridization stability and structure produced blockade currents clearly distinguishable in nanopore recordings, which could be unequivocally assigned to each analyte, thereby enabling accurate differentiation among multiple biomarkers. This assay based on the excellent discrimination ability of the probes facilitates unambiguous identification and quantification of multiple analytes on a natural serum background, thus presenting a powerful tool for biomedical research and clinical practice.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.